ES2095045T3 - Composiciones y procedimientos para la liberacion sostenida de medicamentos. - Google Patents

Composiciones y procedimientos para la liberacion sostenida de medicamentos.

Info

Publication number
ES2095045T3
ES2095045T3 ES93905844T ES93905844T ES2095045T3 ES 2095045 T3 ES2095045 T3 ES 2095045T3 ES 93905844 T ES93905844 T ES 93905844T ES 93905844 T ES93905844 T ES 93905844T ES 2095045 T3 ES2095045 T3 ES 2095045T3
Authority
ES
Spain
Prior art keywords
compositions
medicines
sustained release
procedures
somatropine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93905844T
Other languages
English (en)
Spanish (es)
Inventor
Siva N Raman
Matthew W Gray
Rodger L Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of ES2095045T3 publication Critical patent/ES2095045T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES93905844T 1992-02-10 1993-02-09 Composiciones y procedimientos para la liberacion sostenida de medicamentos. Expired - Lifetime ES2095045T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/833,197 US5328697A (en) 1992-02-10 1992-02-10 Compositions and processes for the sustained release of drugs

Publications (1)

Publication Number Publication Date
ES2095045T3 true ES2095045T3 (es) 1997-02-01

Family

ID=25263729

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93905844T Expired - Lifetime ES2095045T3 (es) 1992-02-10 1993-02-09 Composiciones y procedimientos para la liberacion sostenida de medicamentos.

Country Status (13)

Country Link
US (1) US5328697A (de)
EP (1) EP0625900B1 (de)
JP (1) JPH08502020A (de)
CN (1) CN1071113C (de)
AT (1) ATE145552T1 (de)
AU (1) AU669884B2 (de)
CA (1) CA2129754A1 (de)
DE (1) DE69306243T2 (de)
DK (1) DK0625900T3 (de)
ES (1) ES2095045T3 (de)
NZ (1) NZ249658A (de)
TW (1) TW272133B (de)
WO (1) WO1993015725A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100210509B1 (ko) * 1996-01-10 1999-07-15 성재갑 지속성 동물 성장 호르몬 제형 및 이의 제조 방법
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
GB9910975D0 (en) * 1999-05-13 1999-07-14 Univ Strathclyde Rapid dehydration of proteins
MXPA02004413A (es) * 1999-11-02 2002-09-02 Depomed Inc Induccion farmacologica del modo de alimentacion, para la administracion aumentada de drogas al estomago.
GB0116074D0 (en) * 2001-06-29 2001-08-22 Univ Strathclyde Nanoparticle structures
US7220433B2 (en) * 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
CA2552064A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
DE102005060393A1 (de) 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
FR3007651A1 (fr) * 2013-06-27 2015-01-02 Assist Publ Hopitaux De Paris Composition pharmaceutique sous forme de granules pour le traitement de desordres metaboliques chez l'enfant
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3220925A (en) * 1962-11-15 1965-11-30 Upjohn Co Tetracycline-novobiocin compositions and method of use
BE640616A (de) * 1962-12-19
US3383283A (en) * 1964-01-24 1968-05-14 Merck & Co Inc Medicinal pellets coated with overlapping porous fatty acid leaflet layers
US3365365A (en) * 1965-08-09 1968-01-23 Hoffmann La Roche Repeat action pharmaceutical compositions in the form of discrete beadlets
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung

Also Published As

Publication number Publication date
AU3661093A (en) 1993-09-03
EP0625900B1 (de) 1996-11-27
WO1993015725A1 (en) 1993-08-19
US5328697A (en) 1994-07-12
EP0625900A1 (de) 1994-11-30
CN1075253A (zh) 1993-08-18
TW272133B (de) 1996-03-11
NZ249658A (en) 1996-05-28
DE69306243T2 (de) 1997-03-20
CA2129754A1 (en) 1993-08-11
ATE145552T1 (de) 1996-12-15
AU669884B2 (en) 1996-06-27
CN1071113C (zh) 2001-09-19
JPH08502020A (ja) 1996-03-05
DK0625900T3 (da) 1997-06-02
DE69306243D1 (de) 1997-01-09

Similar Documents

Publication Publication Date Title
ES2095045T3 (es) Composiciones y procedimientos para la liberacion sostenida de medicamentos.
MX9302867A (es) Composiciones refrescantes.
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
ES2107235T3 (es) Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
MX9400166A (es) Microesferas de proteina vegetal, hidrolizada, modificada y metodos para su preparacion y su uso.
HN1997000151A (es) Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente.
ES2128369T3 (es) Procedimiento para la fabricacion de formas farmaceuticas solidas con liberacion prolongada en dos etapas.
ATE172640T1 (de) Transdermale resorption von wirkstoffen aus unterkühlten schmelzen
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
ES2174873T3 (es) Talidomina para inhibir la angiogenesis.
ES2033426T3 (es) Procedimiento para la preparacion de composiciones farmaceuticas de liberacion controlada que contienen 3'-azido-3'-desoxitimidina.
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
PA8472901A1 (es) Formulaciones farmaceuticas
ES2111287T3 (es) Nueva forma cristalina de un analogo de la vitamina d.
AR011728A1 (es) FORMULACIoN FARMACÉUTICA DE GRÁNUKOS ENTÉRICOS DE FLUOXETINA Y SU USO PARA PREPARAR UN MEDICAMENTO.
AR015349A1 (es) Nuevas modificaciones cristalinas del 2-amino-4-(4-fluorbencilamino)-1-etoxicarbonil-aminobenceno y procedimiento para prepararlos, utilizacion de losmismas y medicamento que las contienen
CO5070636A1 (es) Proceso para la preparacion de formas galenicas solidas con liberacion controlada de los ingredientes activos para uso peroral
ES2182874T3 (es) Procedimiento de tratamiento de las uñas.
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ES2188586T3 (es) Utilizacion de inhibidores del complemento para la preparacion de un medicamento para la profilaxis y terapia de enfermedades inflamatorias intestinales y de la piel, asi como purpura.
MX9500159A (es) Preparacion farmaceutica percutanea.
ES2018478B3 (es) Un sistema para preparar una composicion desensibilizante dental.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 625900

Country of ref document: ES